Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc.
Amazon.com (AMZN) - Shares were up 11% following better-than-expected quarterly results issued Thursday evening. Notable sell-side analyst, Laura Martin of Needham, highlighted Amazon's "hidden value,"